Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.67 USD | +0.75% | +15.54% | -36.60% |
26/04 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
25/04 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.60% | 594M | |
+19.53% | 42.68B | |
-1.96% | 42.4B | |
+45.21% | 40.04B | |
-6.20% | 28.31B | |
+6.57% | 24.94B | |
-21.15% | 18.96B | |
+30.32% | 12.3B | |
-2.58% | 11.95B | |
-3.47% | 11.55B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : Credit Suisse Downgrades CureVac to Underperform from Neutral, Adjusts Price Target to $50 from $47